CLINICAL AND TRANSLATIONAL MEDICINE

CLINICAL AND TRANSLATIONAL MEDICINE
Published: (2025)

CLINICAL AND TRANSLATIONAL MEDICINE
Published: (2025)

CLINICAL AND TRANSLATIONAL MEDICINE
Published: (2025)

CLINICAL AND TRANSLATIONAL MEDICINE
Published: (2025)

CLINICAL AND TRANSLATIONAL MEDICINE
Published: (2026)

CLINICAL AND TRANSLATIONAL MEDICINE
Published: (2026)

CLINICAL AND TRANSLATIONAL MEDICINE
Published: (2026)

Illuminating the genomic frontier of invasive non‐typhoidal Salmonella infections
by: Hao Wang, et al.
Published: (2025)

The deubiquitinase OTUD3 plays a neuroprotective role by reducing ferroptosis induced by cerebral ischaemia reperfusion via stabilizing PLK1 via deubiquitination
by: Jing Cheng, et al.
Published: (2025)

PADI4 facilitates stem‐like properties and cisplatin resistance through upregulating PRMT2/IDs family in oesophageal squamous cell carcinoma
by: Zeyu Wang, et al.
Published: (2025)

Irisin‐mediated muscle‐renal crosstalk as a protective mechanism against contrast‐induced acute kidney injury via cGAS‐STING signalling inhibition
by: Long Peng, et al.
Published: (2025)

A comparative genomic study across 396 liver biopsies provides deep insight into FGF21 mode of action as a therapeutic agent in metabolic dysfunction‐associated steatotic liver disease
by: Shifang Tang, et al.
Published: (2025)

The absence of IL17A favours cytotoxic cell function and improves antigen‐specific immunotherapies in pancreatic adenocarcinoma
by: Giorgia Tiberi, et al.
Published: (2025)

Single‐nucleus RNA sequencing reveals the distinct heterogeneity of primary pulmonary sarcomas (PPS) and pulmonary sarcomatoid carcinoma (PSC)
by: Jianfei Zhu, et al.
Published: (2025)

RNF39 promotes colorectal cancer progression by driving RINT1 degradation and suppressing ER stress‐induced apoptosis
by: Lu Chen, et al.
Published: (2025)

Interleukin 27 deficiency drives dilated cardiomyopathy by ferroptosis
by: Yan Zhao, et al.
Published: (2025)

Angiogenesis and targeted therapy in the tumour microenvironment: From basic to clinical practice
by: Shuaixi Yang, et al.
Published: (2025)

Functional genomics pipeline identifies CRL4 inhibition for the treatment of ovarian cancer
by: Sally E. Claridge, et al.
Published: (2025)

Identification of taste cells and reduced taste‐related proteins in saliva correlate with the impaired taste sensitivity in long‐coronavirus disease
by: Parul Patel, et al.
Published: (2025)

CD103+CD8+ tissue‐resident memory T lymphocytes of melanoma boost anti‐tumour immunity and predict immunotherapy outcomes
by: Tianyi Zhang, et al.
Published: (2025)

Altered nicotinamide adenine dinucleotide metabolism drives cartilage degeneration and osteoarthritis
by: Xiaoxin Wu, et al.
Published: (2025)

Neutrophil extracellular traps in cancer: From mechanisms to treatments
by: Yifan Wang, et al.
Published: (2025)

Organoid‐based two‐step drug screening for rapid identification of chemotherapy‐resistant oesophageal squamous cell carcinoma and alternative therapies
by: Chen‐Ye Shao, et al.
Published: (2025)

SHP2 inhibition and adjuvant therapy synergistically target KIT‐mutant GISTs via ERK1/2‐regulated GSK3β/cyclin D1 pathway
by: Chunxiao He, et al.
Published: (2025)

Analysis of hepatitis B virus integration identifies KMT2B as a novel cancer‐related gene in pancreatic cancer
by: Mengge Li, et al.
Published: (2025)

Bispecific antibody targeting CD40 and HER2 potentiates therapeutic efficacy by reprogramming macrophages within the tumour microenvironment
by: Na Li, et al.
Published: (2025)

Immune‐based transcriptomic signature predicts CDK4/6 inhibitor efficacy in HR+/HER2– breast cancer
by: Eudald Felip, et al.
Published: (2025)

Electrospray‐based sample preparation for high‐resolution protein structure elucidation by cryo‐EM
by: Jingjin Fan, et al.
Published: (2025)

Pathogenic variants of TUBB8 cause oocyte spindle defects by disrupting with EB1/CAKP5 interactions and potential treatment targeting microtubule acetylation through HDAC6 inhibition
by: Hui Luo, et al.
Published: (2025)

Targeting enabled homolog with daunorubicin inhibits ERK1/2/c‐Fos pathway and suppresses hepatocellular carcinoma progression
by: Zhi‐Mei Li, et al.
Published: (2025)

CAR‐DC combined with CAR‐T therapy for relapsed/refractory acute myeloid leukaemia: Research progress and future perspectives
by: Rui Zhang, et al.
Published: (2025)

CRISPRi screening identifies PIKfyve as a co‐therapeutic target for obinutuzumab
by: Yerim Kim, et al.
Published: (2025)

Cancer therapy resistance from a spatial‐omics perspective
by: Yinghao Zhang, et al.
Published: (2025)

Vitamin K‐dependent gamma‐carboxyglutamic acid protein 1 promotes pancreatic ductal adenocarcinoma progression through stabilizing oncoprotein KRAS and tyrosine kinase receptor EGFR
by: Zheng Wu, et al.
Published: (2025)

Deciphering the pseudouridine nucleobase modification in human diseases: From molecular mechanisms to clinical perspectives
by: Shiheng Jia, et al.
Published: (2025)

Integrative single‐cell transcriptomic analysis deciphers heterogeneous characteristics of gastrointestinal tract cancer
by: Chuwen Sun, et al.
Published: (2025)